Case File №
#VI-2026-0739
PeptiAtlas
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
30 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | A Great | 4 | 8.8 | 6.3 | 10.0 | 17 Oct 2025 |
| 4-Piperidone CAS 41661-47-6 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 2 Apr 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 |
| Cerebrolysin | X N/A | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 |
| Chonluten | X N/A | 1 | 10.0 | 10.0 | 10.0 | 16 Mar 2025 |
| Dapoxetine | X N/A | 1 | 10.0 | 10.0 | 10.0 | 6 May 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 8.1 | 8.1 | 8.1 | 25 Apr 2025 |
| Dianabol Oil | X N/A | 1 | 9.2 | 9.2 | 9.2 | 28 Mar 2025 |
| Drostanolone Propionate (Mast P) Raw | X N/A | 1 | 8.4 | 8.4 | 8.4 | 13 Jun 2025 |
| Hexarelin | X N/A | 1 | 8.4 | 8.4 | 8.4 | 28 Mar 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 7.5 | 7.5 | 7.5 | 7 May 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 9.3 | 9.3 | 9.3 | 17 Dec 2024 |
| MENT (Trestolone Acetate) | X N/A | 1 | 7.7 | 7.7 | 7.7 | 3 Jul 2025 |
| MK-677 (Ibutamoren) Raw | X N/A | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 |
| MOTS-C | X N/A | 1 | 9.8 | 9.8 | 9.8 | 11 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| NAD+ | X N/A | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 |
| P21 | X N/A | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 |
| Prednisone | X N/A | 1 | 8.2 | 8.2 | 8.2 | 6 May 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 9.1 | 9.1 | 9.1 | 2 Apr 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X N/A | 1 | 9.5 | 9.5 | 9.5 | 13 Jun 2025 |
| Selank | X N/A | 1 | 6.9 | 6.9 | 6.9 | 13 Jun 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 8.7 | 8.7 | 8.7 | 13 Jun 2025 |
| SNAP-8 | X N/A | 1 | 8.3 | 8.3 | 8.3 | 20 Jun 2025 |
| Sustanon 250 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 25 Apr 2025 |
| Test Suspension | X N/A | 1 | 6.9 | 6.9 | 6.9 | 20 Jun 2025 |
| Thymalin | X N/A | 1 | 9.0 | 9.0 | 9.0 | 3 Jul 2025 |
| TriTren 225 | X N/A | 1 | 10.0 | 10.0 | 10.0 | 24 Apr 2025 |
| Turinabol | X N/A | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 |
| Winstrol Oil (Stanozolol) | X N/A | 1 | 10.0 | 10.0 | 10.0 | 3 Jun 2025 |
Exhibit II
Evidence Log
33 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Dapoxetine | 10.0 A | 25mg | 28.5mg | +13.9% | 98.15% | v9hs6w | Lab B | Community |
| 24 May 2026 | MK-677 (Ibutamoren) Raw | 10.0 A | 1g | 1.2g | +22.6% | 95.96% | ktxsdq | Lab B | Community |
| 24 May 2026 | 4-Piperidone CAS 41661-47-6 | 4.8 C | 500g | 547.5g | +9.5% | 97.19% | 7namgo | Lab D | Public |
| 24 May 2026 | Sustanon 250 | 8.3 A | 250mg/ml | 288.7mg/ml | +15.5% | 96.60% | 9kzasw | Lab G | Community |
| 24 May 2026 | Turinabol | 10.0 A | 25mg | 27.5mg | +10.1% | 99.53% | z4v7t8 | Lab C | Public |
| 24 May 2026 | Dianabol Oil | 9.0 A | 100mg/ml | 103.9mg/ml | +3.9% | 95.89% | es7hrk | Lab F | Public |
| 24 May 2026 | Selank | 5.2 B | 30mg | 35.8mg | +19.5% | 97.15% | irilin | Lab E | Public |
| 21 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 10.0 A | 5mg | 4.3mg | -13.1% | 95.54% | 2hywie | Lab B | Community |
| 21 May 2026 | Test Suspension | 6.9 A | 300mg/ml | 265.3mg/ml | -11.6% | 97.35% | jh1g8t | Lab B | Public |
| 21 May 2026 | MOTS-C | 10.0 A | 2mg | 1.9mg | -5.8% | 99.12% | fgdo15 | Lab C | Public |
| 20 May 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 10.0 A | 30mg | 32.7mg | +9.0% | 95.06% | oo58hx | Lab A | Public |
| 20 May 2026 | NAD+ | 9.3 A | 10mg | 10.1mg | +0.9% | 98.16% | r07kdm | Lab D | Public |
| 19 May 2026 | Chonluten | 9.9 A | 5mg | 4.5mg | -10.2% | 98.26% | hw57hi | Lab B | Public |
| 19 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 8.0 A | 15mg | 17.8mg | +18.9% | 98.01% | 40h1my | Lab C | Public |
| 17 May 2026 | LGD-4033 (Ligandrol) | 9.1 A | 100mg | 98.6mg | -1.4% | 99.21% | cc464v | Lab D | Public |
| 17 May 2026 | Retatrutide 30mg Pen Kit | 9.2 A | 30mg | 34.5mg | +14.9% | 96.42% | 0vnaxd | Lab F | Community |
| 19 Jan 2026 | DHB (1-Test Cyp) Oral | 7.1 A | 50mg | 47.3mg | -5.3% | 95.01% | uv31tc | Lab B | Community |
| 6 Jan 2026 | Thymalin | 9.9 A | 2mg | 2.3mg | +14.9% | 99.97% | 5yyp09 | Lab C | Community |
| 13 Dec 2025 | Tirzepatide | 6.3 B | 30mg | 35.8mg | +19.3% | 99.60% | Nov 2 2025 | Lab G | Public |
| 12 Dec 2025 | P21 | 6.6 A | 30mg | 31.6mg | +5.3% | 99.30% | 2dlljk | Lab F | Public |
| 6 Dec 2025 | Tirzepatide | 10.0 A | 50mg | 52.4mg | +4.8% | 99.95% | Oct 15 2025 | Lab E | Public |
| 5 Dec 2025 | Tirzepatide | 9.8 A | 60mg | 59.7mg | -0.5% | 99.80% | Oct 15 2025 | Lab G | Public |
| 5 Dec 2025 | MENT (Trestolone Acetate) | 8.9 A | 200mg/ml | 249.2mg/ml | +24.6% | 98.83% | 6rzifk | Lab D | Public |
| 23 Nov 2025 | Cerebrolysin | 9.6 A | 15mg | 17.5mg | +16.5% | 98.37% | wegge5 | Lab F | Public |
| 23 Nov 2025 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 10.0 A | 25mg | 23.5mg | -6.2% | 96.49% | 4lb1pi | Lab D | Public |
| 14 Nov 2025 | Winstrol Oil (Stanozolol) | 10.0 A | 200mg/ml | 188.2mg/ml | -5.9% | 96.42% | jqj35d | Lab B | Community |
| 5 Nov 2025 | Drostanolone Propionate (Mast P) Raw | 10.0 A | 10g | 10.9g | +9.3% | 98.80% | n17ffi | Lab A | Public |
| 17 Oct 2025 | Tirzepatide | 9.2 A | 60mg | 64.3mg | +7.2% | 99.85% | Sept 4 2025 | Lab E | Public |
| 17 Oct 2025 | Hexarelin | 8.1 A | 15mg | 15.6mg | +4.2% | 95.31% | 9flo6b | Lab A | Community |
| 17 Oct 2025 | Prednisone | 7.6 A | 100mg | 91.1mg | -8.9% | 96.79% | f9cit7 | Lab G | Community |
| 17 Oct 2025 | Retatrutide 5mg + Cagrilintide 5mg Blend | 9.5 A | 2mg | 2.2mg | +12.1% | 97.72% | 26rq1o | Lab F | Public |
| 17 Oct 2025 | TriTren 225 | 8.3 A | 200mg/ml | 183.7mg/ml | -8.2% | 96.30% | t0orxu | Lab E | Public |
| 3 Oct 2025 | SNAP-8 | 8.7 A | 10mg | 8.9mg | -10.9% | 97.04% | bc520a | Lab E | Community |
— END OF EVIDENCE LOG —